1 study found for:    20673995 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
Conditions: Obesity;   Overweight
Interventions: Drug: NB16 (Naltrexone SR 16 mg/bupropion SR 360 mg/day);   Drug: NB32 (Naltrexone SR 32 mg/bupropion SR 360 mg/day);   Drug: Placebo

Indicates status has not been verified in more than two years